Warning: You're using a guest account.
Unless you register as a full user all information associated with this session will be deleted within 24 hours.
LABEL: COVID-19 up whole blood DESCRIPTION: This set describes genes whose transcription is up-regulated in the whole blood of COVID-19 patients versus healthy donors. Genes listed in table S2 were mapped to ENSEMBL identifiers. Values are the reported log2 fold-change.
LABEL: COVID-19 up whole blood (HGNC) DESCRIPTION: This set describes genes whose transcription is upregulated in the whole blood of COVID-19 patients versus healthy donors. Genes listed in table S2 were entered using HGNC identifiers. Identifiers that couldn't be mapped were omited from the set. Values are the reported log2 fold-change.
LABEL: COVID-19 down whole blood DESCRIPTION: This set describes genes whose transcription is downregulated in the whole blood of COVID-19 patients versus healthy donors. Genes listed in table S2 were entered using HGNC Gene identifiers. Genes that could not be converted were omitted from the set. Values are the reported log2 fold-change.
LABEL: COVID-19 down whole blood DESCRIPTION: This set describes genes whose transcription is downregulated in the whole blood of COVID-19 patients versus healthy donors. Genes listed in table S2 were entered using the core ENSEMBL Gene identifiers. Values are the reported log2 fold-change.
LABEL: Up in severe versus mild COVID-19 DESCRIPTION: This set describes genes whose transcription is upregulated in the whole blood of COVID-19 patients versus healthy donors. Genes listed in table S2 were entered using the core ENSEMBL Gene identifiers. Values are the reported log2 fold-change.
LABEL: Down in severe versus mild COVID-19 DESCRIPTION: This set describes genes whose transcription is down-regulated in the whole blood of COVID-19 patients versus healthy donors. Genes listed in table S2 were entered using the core ENSEMBL Gene identifiers. Values are the reported log2 fold-change.
LABEL: severe COVID-19 up whole blood DESCRIPTION: This set describes genes whose transcription is upregulated in the whole blood of severe COVID-19 patients versus healthy donors. Genes listed in table S2 were entered using ENSEMBL Gene identifiers. Values are the reported log2 fold-change.
LABEL: severe COVID-19 down whole blood DESCRIPTION: This set describes genes whose transcription is down-regulated in the whole blood of severe COVID-19 patients versus healthy donors. Genes listed in table S2 were entered using the core ENSEMBL Gene identifiers. Values are the reported log2 fold-change.
LABEL: mild COVID-19 up whole blood DESCRIPTION: This set describes genes whose transcription is upregulated in the whole blood of severe COVID-19 patients versus healthy donors. Genes listed in table S2 were entered using ENSEMBL Gene identifiers. Genes that could not be converted were omitted from the set. Values are the reported log2 fold-change.
LABEL: mild COVID-19 down whole blood DESCRIPTION: This set describes genes whose transcription is down-regulated in the whole blood of mild COVID-19 patients versus healthy donors. Genes listed in table S2 were entered using the core ENSEMBL Gene identifiers. Values are the reported log2 fold-change.
LABEL: down in early COVID-19 granulocytes, severe vs mild DESCRIPTION: This set includes genes that are downregulated in granulocytes from patients with severe versus mild disease at an early stage. Early stage was considered to be from days 1-10 after symptoms. Genes from table S4 were entered using ENSEMBL identifiers. Values given are log2 fold change in expression levels.
LABEL: up in early COVID-19 granulocytes, severe vs mild DESCRIPTION: This set includes genes that are upregulated in granulocytes from patients with severe versus mild disease at an early stage. Early stage was considered to be from days 1-10 after symptoms. Genes from table S4 were entered using ENSEMBL identifiers. Values given are log2 fold change in expression levels.
LABEL: down in late COVID-19 granulocytes, severe vs mild DESCRIPTION: This set includes genes that are downregulated in granulocytes from patients with severe versus mild disease at a late stage. Early stage was considered to be later than 10 days after symptoms. Genes from table S4 were entered using ENSEMBL identifiers. Values given are log2 fold change in expression levels.
LABEL: up in late COVID-19 granulocytes, severe vs mild DESCRIPTION: This set includes genes that are upregulated in granulocytes from patients with severe versus mild disease at a late stage. Early stage was considered to be later than 10 days after symptoms. Genes from table S4 were entered using ENSEMBL identifiers. Values given are log2 fold change in expression levels.